YOLT-202

· RenJi Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YOLT-202, covering 2025-09-26 to 2025-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) [EARLY_Phase 1]